Actuate Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Actuate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Actuate Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Actuate Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $34k | 12k | 2.74 |
| 2025-03-31 | $151k | 22k | 6.77 |
| 2024-12-31 | $90k | 11k | 7.96 |